What is Wave Life Sciences's G&A?

Wave Life Sciences (WVE) reported G&A of $22.1M in Q1 2026.

How has Wave Life Sciences's G&A changed year-over-year?

Wave Life Sciences's G&A increased by 20.4% year-over-year, from $18.36M to $22.1M.

What is the long-term trend for Wave Life Sciences's G&A?

Over 4 years (2021 to 2025), Wave Life Sciences's G&A has grown at a 13.1% compound annual growth rate (CAGR), from $46.11M to $75.33M.

Overhead costs not directly tied to production or sales — corporate management, legal, accounting, office rent, insurance, and other administrative functions.

Wave Life Sciences WVE G&A

G&A at other companies

Beam TherapeuticsBEAM

$34.43M+23.2%

Dyne Therapeutics, Inc.DYN

$24.39M+53.1%

MeiraGTx Holdings plcMGTX

$8.93M-4.7%

Intellia TherapeuticsNTLA

$34.84M+20.1%

Viking TherapeuticsVKTX

$13.98M-0.7%

ImmunomeIMNM

$12.95M+21.1%

Other financials

Income statement

See full

Revenue$38.2M+317%

Operating income-$31.3M+37.2%

Net income-$26.1M+44.4%

EPS (diluted)-$0.13+55.2%

Balance sheet

See full

Cash & equivalents$544.6M+124%

Total debt$15.7M-33.4%

Total equity$511.7M+198%

Total assets$583.5M+102%

Cash flow

See full

Operating cash flow-$59.6M+5.5%

CapEx$438.0K+165%

Free cash flow-$60.0M+5.1%

Valuation

See full

Market cap$1.14B+13.0%

Enterprise value$615.92M-22.3%

P/S15.1×-12.2×

Profitability

See full

Operating margin-75.7%-33.6pp

Net margin-66.5%-29.9pp

FCF margin-27.2%-12.6pp

Returns & leverage

See full

Return on equity-53.7%—

Debt / equity0×-0.1×

Current ratio11.3×+8.3×

Where this comes from

Reported directly by Wave Life Sciences in its filing.

Tagged under the XBRL concept us-gaap:GeneralAndAdministrativeExpense.

The official record: Wave Life Sciences’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Wave Life Sciences's g&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Wave Life Sciences's G&A?: Wave Life Sciences (WVE) reported G&A of $22.1M in Q1 2026.
How has Wave Life Sciences's G&A changed year-over-year?: Wave Life Sciences's G&A increased by 20.4% year-over-year, from $18.36M to $22.1M.
What is the long-term trend for Wave Life Sciences's G&A?: Over 4 years (2021 to 2025), Wave Life Sciences's G&A has grown at a 13.1% compound annual growth rate (CAGR), from $46.11M to $75.33M.
What does G&A mean?: Overhead costs not directly tied to production or sales — corporate management, legal, accounting, office rent, insurance, and other administrative functions.